Research Topics
| S W ChouSummaryAffiliation: Oregon Health and Science University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Human cytomegalovirus UL27 is not required for viral replication in human tissue implanted in SCID miceMark N Prichard
Department of Pediatrics, University of Alabama School of Medicine, Birmingham, AL, USA
Virol J 3:18. 2006..These data are consistent with minimal defects observed in cell culture, but are not consistent with an important role for UL27 in vivo. We conclude that UL27 is not required for viral replication in vivo...
Effects on maribavir susceptibility of cytomegalovirus UL97 kinase ATP binding region mutations detected after drug exposure in vitro and in vivoSunwen Chou
Division of Infectious Diseases, Oregon Health and Science University, Portland, OR 97239, USA
Antiviral Res 95:88-92. 2012..There is a potential for increased maribavir resistance in UL27-UL97 double mutants...
Analysis of the human cytomegalovirus genomic region from UL146 through UL147A reveals sequence hypervariability, genotypic stability, and overlapping transcriptsNell S Lurain
Department of Immunology Microbiology, Rush University Medical Center, Chicago, IL, USA
Virol J 3:4. 2006..UL146 and UL147, which encode CXC chemokine homologues are among these variable ORFs...
Conserved retinoblastoma protein-binding motif in human cytomegalovirus UL97 kinase minimally impacts viral replication but affects susceptibility to maribavirRachel B Gill
Department of Pediatrics, University of Alabama School of Medicine, Birmingham, AL, USA
Virol J 6:9. 2009..Mutation of the amino terminal motif, which is involved in the inactivation of Rb, also renders the virus hypersensitive to the drug and suggests that the motif may play a role in its mechanism of action...
Phenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter geneSunwen Chou
Medical and Research Services, VA Medical Center and Oregon Health and Science University, P3ID 3710 SW US Veterans Hospital Road, Portland, Oregon 97239, USA
Antimicrob Agents Chemother 49:2710-5. 2005..Transfer into strain T2211 facilitates the phenotyping of newly observed mutations, combinations of mutations, and clinical CMV sequences without an accompanying viral isolate...
Effect of cell culture conditions on the anticytomegalovirus activity of maribavirSunwen Chou
Medical and Research Services, VA Medical Center and Oregon Health and Scince University, Portland, OR 97239, USA
Antimicrob Agents Chemother 50:2557-9. 2006..These effects influence the phenotypic assay of drug susceptibility and suggest the possibility of therapeutically useful combinations of maribavir and cellular kinase inhibitors...
Cytomegalovirus UL97 kinase mutations that confer maribavir resistanceSunwen Chou
Oregon Health and Science University and Veterans Affairs Medical Center, Portland, OR, 97239, USA
J Infect Dis 196:91-4. 2007..The 3 UL97 mutations now known to confer MBV resistance are located upstream of UL97 mutations linked to ganciclovir resistance, closer to kinase domains that are associated with adenosine triphosphate binding and phosphotransfer...
Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimensSunwen Chou
Divisionof Infectious Disease, Oregon Health Science University, VA Medical Center, Portland, OR 97239, USA
Antimicrob Agents Chemother 51:4160-2. 2007..Bacterial artificial chromosome CMV clones containing pol mutation L845P were nonviable unless repaired with the wild-type sequence...
Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutantSunwen Chou
VA Medical Center P3ID, 3710 SW U S Veterans Hospital Road, Portland, OR 97239, USA
J Virol 82:246-53. 2008..The existence of viable pol D413A mutants may facilitate the selection of additional drug resistance mutations in vivo and the study of these mutations in vitro...
Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavirSunwen Chou
Division of Infectious Diseases, Oregon Health and Science University, Portland, Oregon, USA
Rev Med Virol 18:233-46. 2008..So far, no UL97 mutations are known to confer resistance to both GCV and MBV...
Contrasting drug resistance phenotypes resulting from cytomegalovirus DNA polymerase mutations at the same exonuclease locusSunwen Chou
Division of Infectious Diseases, Oregon Health and Science University, VA Medical Center, Portland, OR 97239, United States
J Clin Virol 43:107-9. 2008..The levels of resistance conferred by specific mutations are variable, ranging from insignificant resistance to triple-drug resistance...
Diverse cytomegalovirus UL27 mutations adapt to loss of viral UL97 kinase activity under maribavirSunwen Chou
Department of Veterans Affairs Medical Center, Division of Infectious Diseases, Oregon Health and Science University, Portland, Oregon, USA
Antimicrob Agents Chemother 53:81-5. 2009..Although the function of UL27 is unknown, it does not appear to be a direct antiviral target for MBV...
Recombinant phenotyping of cytomegalovirus UL97 kinase sequence variants for ganciclovir resistanceSunwen Chou
Division of Infectious Diseases, Oregon Health and Science University, and Department of Veterans Affairs Medical Center, Portland, Oregon, USA
Antimicrob Agents Chemother 54:2371-8. 2010..This information should improve the interpretation of genotypic data generated by diagnostic laboratories...
Recombinant phenotyping of cytomegalovirus sequence variants detected after 200 or 100 days of valganciclovir prophylaxisSunwen Chou
Division of Infectious Diseases, Oregon Health and Science University, Portland, OR, USA
Transplantation 90:1409-13. 2010..Recombinant phenotyping was performed to determine whether the previously uncharacterized genotypic changes affected ganciclovir susceptibility, especially in those receiving the longer duration of prophylaxis...
Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibilitySunwen Chou
Division of Infectious Diseases, Oregon Health and Science University, Portland, OR, USA
Antimicrob Agents Chemother 55:382-4. 2011..Uncommon mutations M460T and C603R increased cyclopropavir EC(50)s by 8- to 10-fold...
Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapySunwen Chou
Division of Infectious Diseases, Oregon Health and Science University and Department of Veterans Affairs Medical Center, Portland, OR 97239, USA
J Clin Virol 50:287-91. 2011..Cytomegalovirus UL54 DNA polymerase mutations observed in clinical specimens are of diagnostic significance if confirmed to affect antiviral drug susceptibility...
Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposureSunwen Chou
Division of Infectious Diseases, Oregon Health and Science University, Portland, Oregon, USA
Antimicrob Agents Chemother 56:197-201. 2012..Unlike GCV and CDV, exonuclease mutations are not a preferred mechanism of CPV resistance, but mutations in and near pol region III may confer CPV resistance by affecting its recognition as an incoming base for DNA polymerization...
Mutations in the human cytomegalovirus UL27 gene that confer resistance to maribavirSunwen Chou
Medical and Research Services, VA Medical Center and Oregon Health and Science University, Portland, USA
J Virol 78:7124-30. 2004..The UL27 sequence was well conserved in a sample of 16 diverse clinical isolates. Mutation in UL27, a betaherpesvirus-specific early gene of unknown biological function, may adapt the virus for growth in the absence of UL97 activity...
Maribavir antagonizes the antiviral action of ganciclovir on human cytomegalovirusSunwen Chou
Medical and Research Services, VA Medical Center, Oregon Health and Science University, Portland, OR 97239, USA
Antimicrob Agents Chemother 50:3470-2. 2006..Antiviral activities of foscarnet and cidofovir were unaffected by maribavir...
Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapyS Chou
Medical and Research Services, VA Medical Center, Portland, Oregon 97201, USA
J Infect Dis 178:526-30. 1998..6-fold increased ganciclovir resistance. Occurrence of the V809 mutation in 3 unrelated cases suggests that it is a clinically significant viral genetic marker for foscarnet resistance and decreased susceptibility to ganciclovir...
Cytomegalovirus drug resistance and clinical implicationsS W Chou
Infectious Disease Section, VA Medical Center, Portland, Oregon 97201, USA
Transpl Infect Dis 3:20-4. 2001..The emergence of drug resistance may be reduced by optimization of host immunity, use of potent antiviral drug regimens, and adherence to dosing regimens that adequately suppress viral replication...
Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovirSunwen Chou
Medical and Research Services, VA Medical Center, Portland, OR 97201, USA
J Infect Dis 185:162-9. 2002..Low drug levels resulting from oral GCV therapy may predispose the virus to the initial selection of these low-grade UL97 resistance mutations and to later accumulation of other mutations and greater resistance...
Antiviral drug resistance in human cytomegalovirusS Chou
Medical and Research Services, VA Medical Center, Portland, Oregon 97201, USA
Transpl Infect Dis 1:105-14. 1999..This information may help in the selection of alternative therapy...
A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistanceS Chou
VA Medical Center P3ID, Portland, OR 97201, USA
J Infect Dis 182:1765-8. 2000..A single mutation in region V of CMV pol can, therefore, confer multiple drug resistance in a clinical isolate...
A nine-codon deletion mutation in the cytomegalovirus UL97 phosphotransferase gene confers resistance to ganciclovirS Chou
Medical and Research Services, Veterans Affairs Medical Center, Portland, Oregon 97201, USA
Antimicrob Agents Chemother 44:183-5. 2000..The recombinant virus was resistant to ganciclovir (8.4-fold increase in the 50% inhibitory concentration), was sensitive to foscarnet, and replicated normally in cell culture...
Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV LaboratoriesS Chou
VA Medical Center, Portland, Oregon 97201, USA
Antimicrob Agents Chemother 43:1500-2. 1999..Sequence alignments showed >98% interstrain homology and amino acid variation in only 4% of the 1, 237 codons. Almost all variation occurred outside of conserved functional domains where resistance mutations have been identified...
Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirusSunwen Chou
Medical and Research Services, Veterans Affairs Medical Center, and Division of Infectious Diseases, Oregon Health and Science University, Portland, Oregon 97201, USA
J Infect Dis 188:32-9. 2003..This study significantly increases the number of confirmed CMV pol resistance mutations, at both conserved and nonconserved loci, with implications for molecular mechanisms and the genotypic diagnosis of antiviral resistance...
Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirinD V Gopal
Divisions of Gastroenterology and Hepatology, Oregon Health Sciences Center and Portland Veteran Affairs Medical Center, 37 SW US Veterans Hospital Rd, Portland, OR 97201, USA
Liver Transpl 7:181-90. 2001..Multicenter trials using combination therapy to identify factors predictive of response are needed in the subset of patients with progressive allograft injury...
Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantationMichael Y Shapira
Hadassah Hebrew University Medical Center, Jerusalem, Israel
Clin Infect Dis 46:1455-7. 2008..Artesunate treatment resulted in a 1.7-2.1-log reduction in viral load by treatment day 7, with a viral half-life of 0.9-1.9 days, indicating a highly effective block in viral replication...
Analysis of sequence configurations of the ISDR, PKR-binding domain, and V3 region as predictors of response to induction interferon-alpha and ribavirin therapy in chronic hepatitis C infectionMelissa D Murphy
Medical and Research Services, Portland VA Medical Center, Oregon 97201, USA
Dig Dis Sci 47:1195-205. 2002..However, the finding of greater variability among treatment responders in the carboxy end of NS5A suggests that the V3 region merits further investigation...
Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitisAdriana Weinberg
University of Colorado Health Sciences Center, Denver, Colorado, USA
J Infect Dis 187:777-84. 2003..016). The incidence of foscarnet resistance after 6, 9, and 12 months of therapy was 13%, 24%, and 37%, respectively...
Viral and cell cycle-regulated kinases in cytomegalovirus-induced pseudomitosis and replicationLaura Hertel
Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada
PLoS Pathog 3:e6. 2007..Thus, Cdk1 is necessary and sufficient to drive pseudomitosis, whereas a combination of viral and cell cycle-regulated kinases is important during viral replication...
Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipientsJennifer E Marfori
Medical and Research Services, VA Medical Center and Oregon Health and Science University, Portland, OR, USA
J Clin Virol 38:120-5. 2007..We report on two allogeneic stem cell transplant recipients who developed cytomegalovirus disease associated with new viral mutations that conferred antiviral drug resistance...
How evolution of mutations conferring drug resistance affects viral dynamics and clinical outcomes of cytomegalovirus-infected hematopoietic cell transplant recipientsKathryn L Springer
Division of Infectious Diseases, University of Colorado Health Sciences Center, 4200 E. 9th Ave, C-227, Denver, CO 80220, USA
J Clin Microbiol 43:208-13. 2005..Novel antivirals or combination therapy may be required for the treatment of drug-resistant CMV in HCT recipients and perhaps in other severely immunocompromised patients...
HIV protease mutations associated with amprenavir resistance during salvage therapy: importance of I54MMelissa D Murphy
Medical and Research Services, VA Medical Center P3ID, 3710 SW US Veterans Hospital Road, Portland, OR 97239, USA
J Clin Virol 30:62-7. 2004..To examine the clinical significance of HIV protease mutations detected before and after therapy with amprenavir...
Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnetW Lawrence Drew
UCSF Mount Zion Medical Center, University of California, 1600 Divisadero Street, San Francisco, CA 94115, USA
J Clin Virol 37:124-7. 2006..The cytomegalovirus (CMV) UL97 inhibitor drug maribavir (MBV) is undergoing clinical antiviral trials...
Absence of activation of CMV by blood transfusion to HIV-infected, CMV-seropositive patientsW Lawrence Drew
University of California, San Francisco, Mount Zion Medical Center, California 94115, USA
Transfusion 43:1351-7. 2003....
Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolatesGillian M Scott
Virology Research, POWH and UNSW Research Laboratories, Level 3 Clinical Sciences Building, Prince of Wales Hospital, Avoca Street, Randwick, NSW 2031, Australia
Antimicrob Agents Chemother 51:89-94. 2007..The additive effect of multiple mutations on antiviral susceptibility suggests that increasing antiviral-resistant phenotypes can result from different virus-antiviral interactions...
Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis CHugo R Rosen
Division of Gastroenterology, Portland VAMC and Oregon Health Sciences University, 97207, USA
Am J Gastroenterol 97:714-20. 2002....
Cytomegalovirus glycoprotein B groups in human immunodeficiency virus-infected patients with incident retinitisW Lawrence Drew
Mount Zion Medical Center, University of California, San Francisco, CA 94115, USA
J Infect Dis 186:114-7. 2002..These rates were similar among case patients and control subjects and were similar by risk group. The CMV gB2 genotype is not a major determinant of retinitis pathogenicity but appears to be highly prevalent among HIV-infected patients...
Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatmentsThomas D Wu
Department of Biochemistry, Stanford University, Stanford, California 94305, USA
J Virol 77:4836-47. 2003..The presence of mutational clusters provides insight into the complex mutational patterns required for HIV-1 protease inhibitor resistance...
Tumor necrosis factor-alpha promoter polymorphisms and the risk of rejection after liver transplantation: a case control analysis of 210 donor-recipient pairsSaad F Jazrawi
Liver Transplantation Program, the Division of Gastroenterology Hepatology, Portland Veterans Administration Medical Center, OR 97207, USA
Liver Transpl 9:377-82. 2003..In this large case control analysis of patients undergoing liver transplantation for diverse etiologies, TNF promoter polymorphisms were not independently associated with rejection or survival...
Fatal lactic acidosis and acute renal failure after addition of tenofovir to an antiretroviral regimen containing didanosineMelissa D Murphy
Infectious Disease Section, Veterans Affairs Medical Center, and Oregon Health and Science University, Portland, Oregon 97201, USA
Clin Infect Dis 36:1082-5. 2003....
A longitudinal analysis of T-cell epitope-coding regions of hepatitis C virus after liver transplantationHugo R Rosen
Department of Medicine, and Divisions of Gastroenterology Hepatology and Liver Transplantation, and Infectious Diseases, Portland Veterans Affairs Medical Center, Portland, Oregon 97207, USA
Transplantation 74:209-16. 2002..We hypothesized that amino acid substitutions within critical T-cell epitopes could lead to increased severity of HCV disease...
Reconstitution of hepatitis C virus-specific T-cellmediated immunity after liver transplantationScott J Weston
Department of Medicine, Oregon Health and Science University, USA
Hepatology 41:72-81. 2005..Supplementary material for this article can be found on the HEPATOLOGY website (http://interscience. wiley.com/jpages/0270-9139/suppmat/index.html)...
Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitorsMatthew J Gonzales
Division of Infectious Diseases, Department of Medicine, Stanford University, CA, USA
AIDS 17:791-9. 2003..Most NRTI mutations group into one of three clusters, although several (e.g., M184V) occur in multiple mutational contexts...
Research Grants
- ANTIVIRAL DRUG RESISTANCE IN HUMAN CYTOMEGALOVIRUSSunwen Chou; Fiscal Year: 2007....
- ANTIVIRAL DRUG RESISTANCE IN HUMAN CYTOMEGALOVIRUSSunwen Chou; Fiscal Year: 2003....
- ANTIVIRAL DRUG RESISTANCE IN HUMAN CYTOMEGALOVIRUSSunwen Chou; Fiscal Year: 1999..W. Lawrence Drew (UCSF) and from Dr. Alejo Erice (University of Minnesota). ..
- ANTIVIRAL DRUG RESISTANCE IN HUMAN CYTOMEGALOVIRUSSunwen Chou; Fiscal Year: 2010..Detailed understanding of the genetic mechanisms of resistance will improve the design of suitable new drug structures and antiviral targets. ..
